We are live on
!
Find out more
VIA
Virtus Investment Advisers Portfolio holdings
AUM
$429M
1-Year Est. Return
52.52%
This Fund
S&P 500
This Quarter
Est. Return
+23.54%
1 Year Est. Return
+52.52%
3 Year Est. Return
+172.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$429M
AUM Growth
+$66.7M
(+18%)
Cap. Flow
+$19.4M
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
7.64%
Holding
517
New
67
Increased
228
Reduced
168
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$3.47M |
| 2 |
Datadog
DDOG
|
+$2.53M |
| 3 |
Marvell Technology
MRVL
|
+$2.28M |
| 4 |
Western Digital
WDC
|
+$2.19M |
| 5 |
NetApp
NTAP
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$2.17M |
| 2 |
Linde
LIN
|
+$2.08M |
| 3 |
Hershey
HSY
|
+$2.06M |
| 4 |
Live Nation Entertainment
LYV
|
+$1.97M |
| 5 |
Coca-Cola
KO
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.77% |
| 2 | Technology | 15.15% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 12.74% |
| 5 | Consumer Discretionary | 5.44% |
Similar funds
MSG
NL
PG
LFGO
SFWC
RS
T
WBC
Virtus Investment Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, Virtus Investment Advisers held 517 positions worth $429M, up 18% from $363M the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.
Virtus Investment Advisers deployed $19.4M of net new capital in Q2 2026, opening 67 new positions and adding to 228 existing holdings. Its largest new stake was Devon Energy: 74,863 shares worth $3.09M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 32% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ImmunityBio, an estimated $1.47M trimmed.
- Virtus Investment Advisers's largest Q2 2026 buy was Devon Energy: 74,863 shares worth $3.09M.
- Virtus Investment Advisers added most to Omeros in Q2 2026, an estimated $1.26M increase.
- Virtus Investment Advisers's biggest Q2 2026 reduction was ImmunityBio, cutting an estimated $1.47M.
- Virtus Investment Advisers fully exited Day One Biopharmaceuticals in Q2 2026, selling an estimated $2.17M.
- Virtus Investment Advisers's ten largest holdings make up 7.6% of its $429M portfolio in Q2 2026.
- Virtus Investment Advisers opened 67 new positions and closed 54 in Q2 2026.
- Virtus Investment Advisers's portfolio value rose 18% quarter-over-quarter to $429M.
Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.